Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms’ tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine
Background A chemoimmunotherapy regimen consisting of a novel Wilms’ tumor 1 (WT1) peptide-pulsed dendritic cell (WT1-DC) vaccine and multiagent chemotherapy was observed to modulate the tumor microenvironment (TME) to an immunostimulatory state, resulting in conversion surgery in seven out of nine...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2025-07-01
|
| 叢編: | Journal for ImmunoTherapy of Cancer |
| 在線閱讀: | https://jitc.bmj.com/content/13/7/e011426.full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
